Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anne Marie McCarthy
Different Associations of Tumor PIK3CA Mutations and Clinical Outcomes According to Aspirin Use Among Women With Metastatic Hormone Receptor Positive Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Agreement of Self-Reported Hormone Receptor Status With Cancer Registry Data in Young Breast Cancer Patients
Cancer Epidemiology
Cancer Research
Epidemiology
Oncology
Related publications
Associations of Hormone-Related Factors With Breast Cancer Risk According to Hormone Receptor Status Among White and African American Women
Clinical Breast Cancer
Cancer Research
Oncology
Phase 1b Study of Orteronel in Postmenopausal Women With Hormone-Receptor Positive (HR+) Metastatic Breast Cancer
Investigational New Drugs
Oncology
Pharmacology
722: Optimal Timing of Delivery for Women With Breast Cancer According to Hormone Receptor Subtype
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Androgen Receptor Levels and Association With PIK3CA Mutations and Prognosis in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I Trial of Exemestane in Combination With Metformin and Rosiglitazone in Nondiabetic Obese Postmenopausal Women With Hormone Receptor–positive Metastatic Breast Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
Quantitative ER and PgR Assessment as Predictors of Benefit From Lapatinib in Postmenopausal Women With Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Factors Determining Anthracycline Use in Hormone Receptor Positive, Early Stage Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
